Amgen Inc (AMGN)
Gross profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 20,566,000 | 19,739,000 | 19,917,000 | 19,525,000 | 19,265,000 |
Revenue | US$ in thousands | 33,424,000 | 28,190,000 | 26,323,000 | 25,979,000 | 25,424,000 |
Gross profit margin | 61.53% | 70.02% | 75.66% | 75.16% | 75.77% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $20,566,000K ÷ $33,424,000K
= 61.53%
Based on the provided data, the gross profit margin of Amgen Inc has exhibited fluctuations over the years. As of December 31, 2020, the gross profit margin stood at a healthy 75.77%. However, there was a slight decrease in the margin to 75.16% by December 31, 2021. The margin recovered slightly to 75.66% by December 31, 2022.
Subsequently, there was a noticeable decline in the gross profit margin to 70.02% by December 31, 2023, indicating potential challenges in managing the cost of goods sold or pricing strategy. This trend continued with a more significant decrease to 61.53% by December 31, 2024, suggesting a possible impact on profitability from factors such as increased production costs, pricing pressures, or changes in the product mix.
It would be essential for Amgen Inc to closely monitor and analyze the drivers behind these fluctuations in the gross profit margin to ensure sustainable profitability and operational efficiency going forward.
Peer comparison
Dec 31, 2024